Skip to main content

Table 1 Sociodemographic data

From: Predictors of progression of multiple sclerosis in a sample of Egyptian patients

 

RRMS (n = 150)

SPMS (n = 150)

p-value

No.

%

No.

%

Female

114

76

111

74

0.69

Smoking

18

12

34

22.7

0.015*

Comorbidities

18

88

34

77.3

0.015*

DM

6

4

17

11.3

0.028*

DVT

0

0

1

0.7

1

Epilepsy

2

1.3

2

1.3

1

Favism

0

0

1

0.7

1

HTN

6

4

9

6

0.6

Hyperthyroidism

0

0

1

0.7

1

Hypothyroidism

4

2.7

2

1.3

0.68

Thyroiditis

0

0

1

0.7

1

Vitamin D deficiency

18

12

31

19.3

0.04*

Age years, mean ± SD

31.9 ± 6.48

33.08 ± 5.89

0.1

Onset age, mean ± SD

27.4 ± 6.3

28.5 ± 5.36

0.1

Disease duration, mean ± SD

4.52 ± 3.24

5.14 ± 1.48

0.034*

Time before diagnosis, mean ± SD

0.07 ± 0.01

0.32 ± 0.08

 < 0.001*

BMI

26.34 ± 4.72

28.18 ± 5.66

0.002

Educated

135

90

138

92

0.545

Employed

85

56.7

42

28

 < 0.001*

  1. Age: the current age years of the patient in 2022, BMI: body mass index, disease duration: the difference between onset age and current age years, onset age: the age years at which the patient began to have symptoms of MS. Chi-square test was used for qualitative data comparison, while independent t-test was used for qualitative data comparison, *significant p-value at 0.05 level of significance